These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9576006

  • 1. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma.
    Li HL, Shi FD, Bai XF, Huang YM, van der Meide PH, Xiao BG, Link H.
    Clin Immunol Immunopathol; 1998 Apr; 87(1):15-22. PubMed ID: 9576006
    [Abstract] [Full Text] [Related]

  • 2. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD, Bai XF, Li HL, Huang YM, Van der Meide PH, Link H.
    Clin Exp Immunol; 1998 Mar; 111(3):506-12. PubMed ID: 9528890
    [Abstract] [Full Text] [Related]

  • 3. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG, Zhang GX, Xiao BG, Link H.
    Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
    [Abstract] [Full Text] [Related]

  • 4. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells.
    Ma CG, Zhang GX, Xiao BG, Wang ZY, Link J, Olsson T, Link H.
    Ann N Y Acad Sci; 1996 Feb 13; 778():273-87. PubMed ID: 8610980
    [Abstract] [Full Text] [Related]

  • 5. [Mechanism of cellular immunity accommodation in prophylactic effects of nasal tolerance with dual analogue on experimental autoimmune myasthenia gravis in Lewis rats].
    Wang LH, Wang HB, Tian QH, Fu YH, Wang WZ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jul 13; 38(4):244-7. PubMed ID: 15312583
    [Abstract] [Full Text] [Related]

  • 6. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Link H, Ljungdahl A, Höjeberg B, Link J, He B, Qiao J, Melms A, Olsson T.
    Cell Immunol; 1994 Sep 13; 157(2):353-68. PubMed ID: 7520837
    [Abstract] [Full Text] [Related]

  • 7. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD, Bai XF, Xiao BG, van der Meide PH, Link H.
    J Neurol Sci; 1998 Feb 18; 155(1):1-12. PubMed ID: 9562316
    [Abstract] [Full Text] [Related]

  • 8. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor.
    Ma CG, Zhang GX, Xiao BG, Link J, Olsson T, Link H.
    J Neuroimmunol; 1995 Apr 18; 58(1):51-60. PubMed ID: 7537280
    [Abstract] [Full Text] [Related]

  • 9. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B, Deng C, Lee J, Bradley LM, Dalton DK, Christadoss P, Sarvetnick N.
    J Exp Med; 1997 Aug 04; 186(3):385-91. PubMed ID: 9236190
    [Abstract] [Full Text] [Related]

  • 10. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance.
    Wang ZY, He B, Qiao J, Link H.
    J Neuroimmunol; 1995 Dec 04; 63(1):79-86. PubMed ID: 8557828
    [Abstract] [Full Text] [Related]

  • 11. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Qiao J, Melms A, Link H.
    Cell Immunol; 1993 Dec 04; 152(2):394-404. PubMed ID: 8258147
    [Abstract] [Full Text] [Related]

  • 12. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB, Shi FD, Li H, van der Meide PH, Ljunggren HG, Link H.
    Clin Immunol; 2000 May 04; 95(2):156-62. PubMed ID: 10779409
    [Abstract] [Full Text] [Related]

  • 13. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Huang J, Olsson T, He B, Link H.
    J Neurol Sci; 1995 Feb 04; 128(2):167-74. PubMed ID: 7537794
    [Abstract] [Full Text] [Related]

  • 14. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX, Ma CG, Xiao BG, Bakhiet M, Link H, Olsson T.
    Eur J Immunol; 1995 May 04; 25(5):1191-8. PubMed ID: 7774622
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthetic peptides fail to induce nasal tolerance to experimental autoimmune myasthenia gravis.
    Zhang GX, Shi FD, Zhu J, Xiao BG, Levi M, Wahren B, Yu LY, Link H.
    J Neuroimmunol; 1998 May 01; 85(1):96-101. PubMed ID: 9627002
    [Abstract] [Full Text] [Related]

  • 19. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.
    Wang ZY, Qiao J, Link H.
    J Neuroimmunol; 1993 May 01; 44(2):209-14. PubMed ID: 8505410
    [Abstract] [Full Text] [Related]

  • 20. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
    Im SH, Barchan D, Souroujon MC, Fuchs S.
    J Immunol; 2000 Oct 01; 165(7):3599-605. PubMed ID: 11034361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.